BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 8, 2022
View Archived Issues
BMAL1 disruption has an impact on metabolic and liver disease
Read More
Nanoengineered Bifidobacterium bifidum suppresses tumors in vivo
Read More
LABP-73 demonstrates efficacy in preclinical models of chronic asthma
Read More
METTL3 inhibition with STM-2457 leads to antitumor effects in OSCC
Read More
Study finds variants that increase risk of severe COVID-19
Read More
Novartis enters license option agreement with Voyager for AAV capsids for gene therapy programs
Read More
Kidney organoids as models of tubular injury reveal a key role of HDR genes in kidney repair
Read More
SiteOne Therapeutics patents Nav1.7 inhibitors for pain
Read More
Bristol Myers Squibb describes FPR2 and FPR1 agonists
Read More
CTLs and arachidonic acid from the tumor microenvironment induce tumor ferroptosis mediated by ACSL4
Read More
Local hyperthermia therapy activates beige fat through HSF1 and may be helpful against obesity
Read More
Akebia Therapeutics reports prolyl 4-hydroxylase inhibitors
Read More
Bridge signs option agreement for CellionBioMed's ion channel modulator for IPF
Read More
Dana-Farber Cancer Institute patents USP28 inhibitors for cancer
Read More
Sunshine Lake Pharma researchers describe JAK inhibitors
Read More
Ixaka's CELTIC-19 targeted nanoparticle product granted ATMP classification
Read More